Adipotide/FTTP
Adipotide (FTTP) is a chimeric peptide engineered to target the blood vessels associated with white adipose tissue. It combines a prohibitin-binding peptide sequence with the proapoptotic D(KLAKLAK)2 domain. Research focuses on how this dual-action structure may selectively impair adipose tissue vasculature in preclinical studies.
Adipotide/FTTP
Sale!
Adipotide (FTTP) is a chimeric peptide engineered to target the blood vessels associated with white adipose tissue. It combines a prohibitin-binding peptide sequence with the proapoptotic D(KLAKLAK)2 domain. Research focuses on how this dual-action structure may selectively impair adipose tissue vasculature in preclinical studies.
$120.00
Buy more, save more!
-
Save 2%
Buy 3, get $2.50 off each
$120.00Per item: $117.50Total price: $352.50 -
Save 3%
Buy 5, get $3.75 off each
$120.00Per item: $116.25Total price: $581.25 -
Save 6%
Buy 10, get $7.50 off each
$120.00Per item: $112.50Total price: $1,125.00
$125.00$120.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
Adipotide, commonly referred to as FTPP (Fat Targeted Proapoptotic Peptide), is a synthetic investigational compound developed for obesity research by targeting the vascular system of fat tissue. It is described as a peptidomimetic designed to selectively induce the destruction of fat cells.
The peptide contains a “homing” sequence that recognizes a specific protein expressed in the blood vessels supplying white adipose tissue. After binding to these vessels, it initiates apoptosis, or programmed cell death. By disrupting the delivery of oxygen and nutrients to fat cells, the adipose tissue gradually breaks down and is naturally cleared by the body.
Common research areas include:
- Adipose tissue apoptosis and targeted vascular disruption
- Obesity and metabolic disorder models
- Insulin sensitivity and glucose regulation
- Fat metabolism pathways
There are no reviews yet.